Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-LONG: rFVIIIFc in Severe Hemophilia A
NCT01181128Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2010
- Primary completion
- Aug 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 19
01
Overview
A Phase 3 trial of eftrenonacog alfa in hemophilia A, sponsored by Sanofi. Started Nov 2010; status: completed.
02
Drugs
eftrenonacog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01181128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181128.